People · Operator
Named in public records as an officer, director or promoter · active 2016–2022 · Manufacturing, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Advantest Corp | — | Manufacturing | Series B | $26.1M | $204.8M | 2022 |
| Cb Therapeutics Inc. | — | Other Health Care | Seed | $4.0M | $99.1M | 2016 |
Alex Wu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Alex Wu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Wang | 1 | 5 |
| Guoliang Yu | 1 | 4 |
| Steven Hsieh | 1 | 2 |
| Hisako Takada | 1 | 1 |
| Yasushi Yoshimoto | 1 | 1 |
| Andre Vachenauer | 1 | 1 |
| Naoto Nishida | 1 | 1 |
| Kazuyuki Yamashita | 1 | 1 |
| Daisuke Watanabe | 1 | 1 |
| Yong Xu | 1 | 1 |
| Ralf Stoffels | 1 | 1 |
| Sanjeev Mohan | 1 | 1 |
| Yasuo Mihashi | 1 | 1 |
| Masayuki Suzuki | 1 | 1 |
| Douglas Lefever | 1 | 1 |
| Jintie Li | 1 | 1 |
| Nicholas Benes | 1 | 1 |
| Makoto Nakahara | 1 | 1 |
| Kesa Yorozu | 1 | 1 |
| Richard Junger | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.